The "cutting" edge: Von Willebrand factor-cleaving protease activity in thrombotic microangiopathies

Transfusion and Apheresis Science

Volumn 32, Issue 2, 2005, Pages 177-184

  Haspel, Richard L ^a   Jarolím, Petr ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ADAMTS 13; HUS; Thrombotic microangiopathy; TTP; Von Willebrand factor cleaving protease (VWF cleaving protease)

Indexed keywords

PROTEINASE; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

AUTOIMMUNE DISEASE; BONE MARROW TRANSPLANTATION; CANCER; DIFFERENTIAL DIAGNOSIS; ENZYME ACTIVITY; ENZYME ASSAY; GENETIC DISORDER; HEMOLYTIC UREMIC SYNDROME; HUMAN; IMMUNORADIOMETRIC ASSAY; KIDNEY FAILURE; PATHOGENESIS; PREGNANCY; PROGNOSIS; PROTEIN DEGRADATION; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; TREATMENT OUTCOME;

EID: 15244357262     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2004.10.017     Document Type: Article

References (36)

1. J.L. Moake Thrombotic microangiopathies N Engl J Med 347 2002 589 600
2. H.M. Tsai Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion Blood 87 1996 4235 4244
3. M. Furlan, R. Robles, and B. Lamie Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis Blood 87 1996 4223 4234
4. G. Remuzzi Is ADAMTS-13 deficiency specific for thrombotic thrombocytopenic purpura? No J Thromb Haemost 1 2003 632 634
5. H.M. Tsai Is severe deficiency of ADAMTS-13 specific for thrombotic thrombocytopenic purpura? Yes J Thromb Haemost 1 2003 625 631
6. E. Moschowitz Hyaline thrombosis of the terminal arterioles and capillaries: a hitherto undescribed disease Proc NY Pathol Soc 24 1924 21 24
7. Lukes RJ, Rath CE, Steussy CN, Maillaird J. Thrombotic thrombocytopenic purpura: Clinical and pathologic findings in 49 cases (Abstr.). Proc Am Soc Hematol, Montreal, 1960. 1961;Blood 17, p. 366
8. Lukes RJ, Rath CE, Steussy CN, Maillaird J. Thrombotic thrombocytopenic purpura: Clinical and pathologic findings in 49 cases (Abstr.). Proc Am Soc Hematol, Montreal, 1960. 1961;Blood 17, p. 366
9. E.L. Amorosi, and J.E. Ultmann Thrombotic Thrombocytopenic purpura: report of 16 cases and review of the literature Medicine 45 1966 139 159
10. C.E. Thompson, L.E. Damon, C.A. Ries, and C.A. Linker Thrombotic microangiopathies in the 1980s: clinical features, response to treatment, and the impact of the human immunodeficiency virus epidemic Blood 80 1992 1890 1895
11. C. Gasser, E. Gautier, A. Steck, R.E. Siebenmann, and R. Oechslin Haemolytisch-uraemische syndrome: bilaterale nierenrendennekrosen bei akuten erworbenen hameolytischen anaemien Schweiz Med Wochenschr 85 1955 905 909
12. J.N. George How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Blood 96 2000 1223 1229
13. G.A. Rock, K.H. Shumak, N.A. Buskard, V.S. Blanchette, J.G. Kelton, and R.C. Nair Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group N Engl J Med 325 1991 393 397
14. J.L. Moake, C.K. Rudy, J.H. Troll, M.J. Weinstein, N.M. Colannino, and J. Azocar Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura N Engl J Med 307 1982 1432 1435
15. J.L. Moake von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura Semin Hematol 41 2004 4 14
16. K. Fujikawa, H. Suzuki, B. McMullen, and D. Chung Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family Blood 98 2001 1662 1666
17. H.E. Gerritsen, R. Robles, B. Lammle, and M. Furlan Partial amino acid sequence of purified von Willebrand factor-cleaving protease Blood 98 2001 1654 1661
18. G.G. Levy, W.C. Nichols, E.C. Lian, T. Foroud, J.N. McClintick, and B.M. McGee Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura Nature 413 2001 488 494
19. A. Veyradier, and J.P. Girma Assays of ADAMTS-13 activity Semin Hematol 41 2004 41 47
20. M. Furlan, R. Robles, M. Galbusera, G. Remuzzi, P.A. Kyrle, and B. Brenner von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome N Engl J Med 339 1998 1578 1584
21. J.A. Hovinga, J.D. Studt, L. Alberio, and B. Lammle von Willebrand factor-cleaving protease (ADAMTS-13) activity determination in the diagnosis of thrombotic microangiopathies: the Swiss experience Semin Hematol 41 2004 75 82
22. S.K. Vesely, J.N. George, B. Lammle, J.D. Studt, L. Alberio, and M.A. El Harake ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients Blood 102 2003 60 68
23. M. Matsumoto, H. Yagi, H. Ishizashi, H. Wada, and Y. Fujimura The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome Semin Hematol 41 2004 68 74
24. H.M. Tsai, and E.C. Lian Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura N Engl J Med 339 1998 1585 1594
25. A. Veyradier, B. Obert, A. Houllier, D. Meyer, and J.P. Girma Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies: a study of 111 cases Blood 98 2001 1765 1772
26. X.L. Zheng, R.M. Kaufman, L.T. Goodnough, and J.E. Sadler Effect of plasma exchange on plasma ADAMTS13 metalloprotease activity, inhibitor level, and clinical outcome in patients with idiopathic and non-idiopathic thrombotic thrombocytopenic purpura Blood 103 2004 4043 4049
27. G. Remuzzi, M. Galbusera, M. Noris, M.T. Canciani, E. Daina, and E. Bresin von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome Blood 100 2002 778 785
28. J.D. Studt, M. Bohm, U. Budde, J.P. Girma, K. Varadi, and B. Lammle Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma: a multicenter comparison of different assay methods J Thromb Haemost 1 2003 1882 1887
29. P.M. Mannucci, M.T. Canciani, I. Forza, F. Lussana, A. Lattuada, and E. Rossi Changes in health and disease of the metalloprotease that cleaves von Willebrand factor Blood 98 2001 2730 2735
30. A.H. Loof, H.H. van Vliet, and M.C. Kappers-Klunne Low activity of von Willebrand factor-cleaving protease is not restricted to patients suffering from thrombotic thrombocytopenic purpura Br J Haematol 112 2001 1087 1088
31. V. Bianchi, R. Robles, L. Alberio, M. Furlan, and B. Lammle Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura Blood 100 2002 710 713
32. J.C. Moore, C.P. Hayward, T.E. Warkentin, and J.G. Kelton Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders Blood 98 2001 1842 1846
33. T. Raife, B. Atkinson, R. Montgomery, S. Vesely, and K. Friedman Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients Transfusion 44 2004 146 150
34. Y. Mori, H. Wada, E.C. Gabazza, N. Minami, T. Nobori, and H. Shiku Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity Transfusion 42 2002 572 580
35. H.M. Tsai, A. Li, and G. Rock Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura Clin Lab 47 2001 387 392
36. R. Yomtovian, W. Niklinski, B. Silver, R. Sarode, and H.M. Tsai Rituximab for chronic recurring thrombotic thrombocytopenic purpura: a case report and review of the literature Br J Haematol 124 2004 787 795